We used exogenous monoclonal antibodies to neutralize IL-1, IL-6, TNF-α or BAFF in the sera, respectively, and then examined whether SLE-serum induced increase of MHC-II expression is suppressed. The gene discussed is IL6; the disease is systemic lupus erythematosus.